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Abstract
The problem of antimicrobial resistance has led Health
Services take to stop population from self-medicating. The
use of antibiotics to trigger a possible mutation of the
most common bacteria of which the human being has
contact, so it is important to evaluate the consequences.
The present study was to evaluate the antibacterial
sensitivity necessary to determine the antibiotic to be
prescribed; were analyzed cultures of 48 patients who
already referred symptoms were used between hospital
inpatients and outpatients, of different sex and age
ranges groups. The biological samples were vaginal
exudates and urine cultures. The results reports indicate
that resistance predominates over sensitivity, a fact that
must draw attention to taking decisive measures in this
regard.
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Introduction
Antimicrobial chemotherapy can be defined as treatment
with antimicrobial chemicals by general or systemic means (as
opposed to local or topical antiseptics). Antimicrobial
chemotherapy, antibiotics or anti-infective are substances of
selective toxicity, that is, they must be much more toxic to the
microorganism (or parasite) that causes the infection than to
the host. Scientific antimicrobial chemotherapy began in 1909
with Paul Ehrlich, using the treatment of syphilis with
Salvarsán. Ehrlich spoke of a magical projectile capable of
killing the infectious agent without causing harm to the
patient.
Antibiotics were originally considered to be natural
antimicrobials and chemotherapeutic ones were those of
synthetic origin. Today this distinction is not used, and both
terms are considered synonymous. Hence, the term
antimicrobial has been generalized to encompass both. When
an infection is treated with bacteriostatic antibiotics, we rely
on the host's defenses, to finally destroy the infecting agent
(whose growth is only stopped by the antibiotic) and
completely eliminate the infections.
When chemotherapy is used to treat infections in patients
with diminished defense mechanisms (immunosuppressed),
always use bactericidal antibiotics, because not only can rely
on the action of the antibiotic [1].
Desirable properties of antimicrobials
The ideal antimicrobial used for chemotherapeutic purposes
is characterized by a number of properties.
• Selective toxicity is an essential property of a
chemotherapeutic agent, which must inhibit or destroy the
pathogens without harming the host.
• The ideal chemotherapeutic agent has a bactericidal rather
than bacteriostatic action. 3) The ideal chemotherapeutic
agent is one for which susceptible microorganisms do not
become genetically or phenotypically resistant.
• That the agent is effective against a broad spectrum of
microorganisms that are found most frequently in clinical
practice.
• The ideal agent should not be allergenic nor cause adverse
side effects due to the continuous administration of large
doses.
• The agent must remain active in the presence of plasma,
body fluids or exudates.
• The agent must be water-soluble and stable, and
bactericidal levels in the organism must be reached quickly
and maintained for prolonged periods [2,3].
Antibiotics
The term "antibiotic" refers to a substance produced by a
microorganism or a similar substance made completely or
partially by chemical synthesis, which at low concentrations
inhibits the development of other microorganisms. The
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wide distribution in nature, where they play an important role
in the regulation of the microbiological populations of soil,
water, and manure. The chemical, physical and
pharmacokinetic properties of antibiotics are very varied, as
are their antimicrobial spectrum and their mechanisms of
action. Of the several hundred naturally-produced antibiotics
that have been purified, only a few have proved sufficiently
non-toxic to be used in medical practice. Those that currently
have the greatest use have been obtained from a relatively
small group of microorganisms belonging to the genera:
Penicillium, Streptomyces, Cephalosporium, Micromonospora
and Bacillus [4].
Mechanism of action
Antibiotics are classified based on their chemical structure
and mechanism of action as follows, observing some examples
in Table 1:
• Antimicrobials that act in the synthesis of the cell wall.
• Inhibitors of protein synthesis
• Inhibitors of nucleic acid synthesis
• Folate inhibitors
• Antimicrobials that act on the outer and cytoplasmic
membranes [5,6]
Table 1 Classification of antibiotics by their mechanism of
action [4].
Target Group of antibiotics
Bacterial wall Betalactamics, vancomycin
Ribosomes Aminoglycosides, macrolides
Via folic acid Sulfonamides, trimetropin
DNA replication Quinolones
Antimicrobial resistance
It is called the clinical resistance of a bacterium to an
antibiotic, to the inability of that antibiotic to cure an infection
for that bacterium.
Natural resistance: There are groups and species of bacteria
that are always resistant to one type of antibiotic: for example,
all anaerobic bacteria are resistant to aminoglycosides.
Pseudomonas aeruginosa is resistant to penicillin.
Acquired resistance: A microorganism that was originally
sensitive to an antimicrobial becomes resistant to it (the
antibiotic that previously served to treat these infections is no
longer valid), nowadays very frequent with the abuse and its
massive use of antibiotics. Microorganisms can develop
resistance by very different mechanisms: a) because they learn
to produce inactivating enzymes that destroy the antibiotic
(destruction of beta-lactamases, by beta-lactam antibiotics), b)
because they alter the wall in such a way that they prevent the
penetration of the antibiotic [7].
Transmissible resistances: When the resistance is the
consequence of a mutation, when a microorganism becomes
resistant to the antibiotic its descendants inherit this
characteristic, and over time this resistance diffuses widely
among all the bacteria of the same species, another the
microorganism transmits this resistance without the need for
these to be their descendants, using the mechanism of
transfer of genetic material.
Multiresistant: The bacteria are simultaneously resistant to
many antibiotics: 1) against a group of analogous antibiotics
(cross resistance), usually due to the appearance of a
mechanism of inactivation of this group of antibiotics. Eg:
emergence of resistance of P. aeruginosa to penicillin and
cephalosporin by production of highly active beta-lactamases.
Or the appearance of Staphylococcus aureus resistant to all
beta-lactams by a mutation that causes a change in its target
cell wall. 2) Multiresistance can also arise due to a generalized
loss of permeability of the bacteria to antibiotics. Eg: S. aureus
simultaneously resistant to beta-lactams, quinolones and
other antibiotics. This happens because the wall of bacteria
does not allow the passage of antibiotics inside them and then
they cannot act on their targets [8].
Causes of resistance to antimicrobial agents
For antimicrobial drug therapy to be effective, the drug
must reach the site of contamination or infection in adequate
concentration.
The bacterial resistance to an antibiotic can be attributed to
three general mechanisms: 1) the drug does not reach its
target; 2) the drug is not active or 3) the target is altered
[8-10].
The outer membrane of gram-negative bacteria is a
permeable barrier that prevents the penetration of large polar
molecules. Small polar molecules, like many antibiotics,
penetrate the cell through a group of protein channels called
porins.
The absence, mutation or loss of a porin decreases the
speed with which the drug penetrates the cell or even
prevents its entry, thus reducing the concentration of the drug
in its target. When the target is intracellular, and the drug
requires active transport through the cell membrane, any
mutation or phenotypic change that interrupts this transport
mechanism confers resistance. For example, gentamicin, which
targets ribosomes, is actively transported through the cell
membrane using the energy provided by the electrochemical
gradient of the membrane. This gradient is generated by
respiratory enzymes that combine the transport of electrons
with oxidative phosphorylation.
Any mutation in an enzyme of this route or anaerobic
circumstances (oxygen is the terminal electron acceptor of this
route and its absence decreases the energy potential of the
membrane) reduces the speed with which gentamicin
penetrates the cell, causing resistance. In addition, the
bacteria have an exit pump that can transport the drugs to the
outside of the cell.
The second general mechanism of drug resistance is
pharmacological inactivation. Bacterial resistance to
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aminoglycosides and β-lactam antibiotics is almost always due
to the production of an enzyme that modifies the
aminoglycosides or a β-lactamase, respectively. A variation of
this mechanism is the failure of the bacterial cell to activate a
prodrug [11].
The third general mechanism of pharmacological resistance
is the presence of an altered target. The reason is perhaps the
mutation of the natural target (E.g. resistance to
fluroquinolone), the modification of the target (e.g., ribosomal
protection resistance to macrolides and tetracyclines) or the
acquisition of a resistant variety of an objective that is
naturally sensitive (e.g., Staphylococcus resistance to
methicillin through the production of a low affinity penicillin
binding protein).
Likewise, pharmacological resistance can be acquired by
mutation and selection, with which the character is transferred
vertically to the daughter cells. For mutation and selection to
generate resistance, the mutation must not be fatal, nor must
it modify virulence to an important degree [6].
Drug resistance is usually acquired by horizontal transfer of
the factors that define it from a donor cell, often from another
bacterial species, by transduction, transformation or
conjugation. The horizontal transfer of resistance offers several
additional advantages to mutation-selection.
a) Mutation-selection: The mutation and selection of the
antibiotic from a mutant and resistant strain constitutes the
molecular basis of resistance to streptomycin (ribosomal
mutation), to quinolones (mutation of the gyrase gene or
topoisomerase IV), rifampicin (mutation of the polymerase
gene) of RNA), and linezolid (mutation of ribosomal RNA).
Mutations can appear in the gene encoding: 1) the protein
target, modifying its structure so that it no longer binds to the
drug; 2) a protein that participates in the transport of the
drug; 3) a protein that is important for the activation or
inactivation of the drug, as is the case of broad-spectrum beta-
lactamases, or 4) in a regulatory or promoter gene that
modifies the expression of a target, a transport protein or a
inactivating enzyme. Mutations are not produced solely by
contact with the drug [7].
b) Horizontal gene transfer: The horizontal transfer of
resistance genes is facilitated by a group of mobile genetic
elements. However, in this process also other mobile
elements, transposable elements, integrates and genetic
cassettes participate. The transposable elements are of three
general types: insertion sequences, transposons and
transposable phages; two of these, insertion sequences and
transposons, are important for resistance. The insertion
sequences are shorter segments of DNA encoding enzymatic
functions for the specific recombination of certain sites with
inverted repeat sequences at either end. They can be copied
themselves and inserted into the chromosome or a plasmid.
Insertion sequences do not encode resistance, but function as
sites of integration for other resistance encoding elements, for
example, plasmids or transposons.
c) Transduction: It is the acquisition of bacterial DNA from a
phage (a virus that spreads in bacteria) that has incorporated
DNA from a previous bacterial host into its outer protein coat.
When the DNA comprises a drug resistance gene, the newly
infected bacterial cell acquires resistance. Transduction is of
special importance in the transfer of resistance to antibiotics
among Staphylococcus aureus strains.
d) Transformation: The transformation is uptake and
incorporation into the host genome, through homologous
recombination of free DNA, released into the environment by
other bacterial cells. This phenomenon constitutes the
molecular basis of resistance to penicillin in pneumococci and
Neisseria [12-15]. Penicillin-resistant pneumococcus produces
altered penicillin-binding protein (PBP) proteins that have a
very low affinity for this antibiotic. The nucleotide sequence
analysis of the genes encoding these modified PBPs indicates
that they are mosaics, where foreign DNA blocks have been
imported from a similar species of streptococcus [6].
e) Conjugation: The conjugation is the transfer of genes by
direct contact between two cells through a pilus or sexual
bridge. This complex and fascinating mechanism for the
dissemination of antimicrobial resistance is very important
since it is possible to transfer several resistance genes in a
single event. The transferable genetic material costs two
groups of genes encoded by plasmids that are in the same
plasmid or in different plasmids. One group encodes the real
resistance and the other encodes the genes necessary for the
bacterial conjugation process [12]
Materials and Methods
For the processing, samples were taken from patients with
previous indications, (vaginal exudate and urine culture). Then
the samples were identified in the log, (with registration
number, type of sample, shift and date).
The urine samples were cultivated in agar muller Hilton,
blood, Mac Conkey, MS and Biggy, by the technique of stria,
incubated at 37 degrees centrigrados for 24 hours, proceeded
to realize the colony count (CFU/mL), staining was performed
to perform the morphological identification (Gram positive or
negative, cocci or bacilli) perform biochemical tests (LIA, TSI,
MIO, CITRATE OF SIMMONS, UREA), catalase test and finally
antibiogram [13]
The samples of vaginal exudate were measured pH, with a
swab made a direct gram, placed in Stuart transport medium,
then in thioglycollate, from there cultivate on Tayer Martin
agar, blood, Mac Conkey, salt and mannitol and Biggy, by the
technique of stria, to later perform antibiogram
After the colonies were identified, Gram was performed,
biochemical tests were performed on LIA, TSI, MIO, Simmons
Citrate, Ures oxidase, and antibiograms with gram (-) and
Gram (+) multidiscs [14-16].
Results and Discussion
From a total of 168 antimicrobial resistance tests for
Escherichia coli, it was found that 52% of the bacteria are
resistant to some type of antibiotic, 44% are sensitive and 4%
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are classified as intermediate sensitivity, in the same way it
was observed that the Amikacin has total sensitivity, to a
lesser degree, Netilmicin, followed in descending form of
chloramphenicol and nitrofurantoin. The resistance is
observed marked although there was some sensitivity for
some patients, the antibiotic Ampicillin is one of those that
have reached more resistivity, followed by Cefalotin, and
Trimethoprim-Sulfamethoxazole, followed by Ceftriaxone,
Cefotaxime and Pefloxacin, so it can be mentioned that some
bacteria reviewed show both sensitivity and resistance, as can
be seen in Tables 2 and 3 and Figure 1.
Table 2 Statistics on the results of sensitivity and drug resistance of the microorganism Escherichia coli.
Patients
Gram (-) antibiotic 1 2 3 4 5 6 7 8 9 10 11 12 13 14
CF R R R 0 I R R R R R R 0 R R
CL R R R 0 0 0 R 0 0 R 0 0 0 0
CRO R R R 0 0 R R R R R R 0 R 0
AM R R R 0 0 R R R R R R R R R
AK 0 0 0 0 0 0 0 0 0 0 0 0 0 0
SXT R R R R 0 R R R R R R 0 0 R
CTX R R R 0 0 R R R R R R 0 R 0
GE R R R 0 0 0 R R 0 R 0 0 R 0
NET 0 I 0 0 0 0 0 0 0 R I 0 R 0
FEP R R R 0 0 R R R R R R 0 R 0
NF I I 0 0 0 R 0 R 0 R 0 0 0 0
LEV R R 0 0 0 0 R R R R R 0 R 0
TE R R - - - - - - - R - - - -
CXM R R - - - - - - - R - - - -
SAM - 0 - - - - - - - R - - - -
DC - R - - - - - - - - - - - -
IPM - - - - - - - - - 0 - - - -
MEM - - - - - - - - - 0 - - - -
*Note: Sensidisks only used with those microorganisms in the majority of the others are resistant. TE, CXM, SAM, DC, IPM, MEM.




Cefalotina (CF) 2 11 1
Chloranphenicol (CL) 9 5 -
Ceftriaxone (CRO) 4 10 -
Ampicilin (AM) 2 12 -





Cefotaxime (CTX) 4 10 -
Gentamicin (GE) 7 7 -
Netilmicin (NET) 10 2 2
Pefloxacin (FEP) 4 10 -
Nitrofurantoin (NF) 9 2 3
Levofloxacin (LEV) 6 8 -
Tetracycline (TE) - 3 -
Cerufoxime (CXM) - 3 -
Ampicilin-Salbutam
(SAM) - 1 1
Imipenem (IPM) 1 - -
Meropenem (MEM) 1 - -
Of the antibiotics for Gram-negative microorganisms,
Amikacin (AK) was the one that predominated with sensitivity,
followed by Netilmicin (NET), Chloramphenicol (CL),
Gentamicin (GE), and Levofloxacin (LEV), and with resistivity
on the part of Ampicillin (AM) was found in all bacteria, and
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resistance was found in most of the bacteria found:
Trimethoprim-Sulfamethoxazole (SXT), and Cefotaxime (CTX).
Figure 1 Results of 168 antimicrobial susceptibility tests for
Escherichia coli.
Conclusion
It was observed that the inadequate use of drugs by
patients is generating a resistance to antimicrobials by
microorganisms, which has led to possible bacterial mutations,
so that day by day is observed greater lack of effectiveness of
drugs employees as part of the treatments established by
doctors.
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